Comparative AAPOS Validation of the blinq. Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus [Response to Letter]

Robert W Arnold Pediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, Anchorage, Alaska 99508, USACorrespondence: Robert W ArnoldPediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, 3500 Latouche #280, Anchorage, Alaska...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Arnold RW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/94fd9d1f52bc479a851c33684d4d580d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Robert W Arnold Pediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, Anchorage, Alaska 99508, USACorrespondence: Robert W ArnoldPediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, 3500 Latouche #280, Anchorage, Alaska 99508, USATel +1 (907)561-1917Fax +1 (907)563-5373Email eyedoc@alaska.net Since I was first introduced to the amazing concept of bilateral birefringent screening championed by David G Hunter and David Guyton decades ago, I have been longing to try the technology on my patients so I  purchased the blinq.™ device as soon as it became commercially available in late 2019.   View the original paper by Arnold   This is in response to the Letter to the Editor